Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00325130
Status:
COMPLETED
Last Update Posted:
2015-03-12
First Post:
2006-05-11
Brief Title:
Concomitant Use of Gardasil V501 Human Papillomavirus Types 6 11 16 18 Recombinant Vaccine With Combined Diphtheria Tetanus Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents V501-025
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Organization Data
Organization:
Merck Sharp Dohme LLC
Class:
INDUSTRY
Study ID:
V501-025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merck Sharp Dohme LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None